A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential-Reference-Cited by-同舟云学术

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential

Published:2021-03 Issue:1 Volume:2 Page:101-113
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Gai Junwei¹,Ma Linlin²,Li Guanghui¹,Zhu Min¹,Qiao Peng¹,Li Xiaofei¹,Zhang Haiwei³,Zhang Yanmin⁴,Chen Yadong⁴,Ji Weiwei¹,Zhang Hao¹,Cao Huanhuan¹,Li Xionghui¹,Gong Rui³,Wan Yakun¹

Affiliation:

1. Shanghai Novamab Biopharmaceuticals Co., Ltd Shanghai China

2. Shanghai Key Laboratory of Molecular Imaging Shanghai University of Medicine and Health Sciences Shanghai China

3. CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega‐Science Chinese Academy of Sciences Wuhan China

4. Laboratory of Molecular Design and Drug Discovery, School of Science China Pharmaceutical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.60

Reference33 articles.

1. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak

2. A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

3. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

4. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

5. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2;International Journal of Molecular Sciences;2024-08-30

2. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11

3. Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review);Molecular Medicine Reports;2024-06-26

4. Escherichia coli and Pichia pastoris : microbial cell-factory platform for full-length IgG production;Critical Reviews in Biotechnology;2024-05-26

5. Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons;World Journal of Microbiology and Biotechnology;2024-05-21